IN2003CH00929A - - Google Patents

Download PDF

Info

Publication number
IN2003CH00929A
IN2003CH00929A IN929CH2003A IN2003CH00929A IN 2003CH00929 A IN2003CH00929 A IN 2003CH00929A IN 929CH2003 A IN929CH2003 A IN 929CH2003A IN 2003CH00929 A IN2003CH00929 A IN 2003CH00929A
Authority
IN
India
Prior art keywords
sub
pcaf
mum
compounds
useful
Prior art date
Application number
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to IN929CH2003 priority Critical patent/IN2003CH00929A/en
Priority to PCT/IB2004/052294 priority patent/WO2005047457A2/en
Priority to US10/579,219 priority patent/US7402706B2/en
Priority to AT04799059T priority patent/ATE549309T1/de
Priority to EP04799059A priority patent/EP1694622B1/en
Publication of IN2003CH00929A publication Critical patent/IN2003CH00929A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/747—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/78—Separation; Purification; Stabilisation; Use of additives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/687—Unsaturated compounds containing a keto groups being part of a ring containing halogen
    • C07C49/697—Unsaturated compounds containing a keto groups being part of a ring containing halogen containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14—All rings being cycloaliphatic
    • C07C2602/24—All rings being cycloaliphatic the ring system containing nine carbon atoms, e.g. perhydroindane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
IN929CH2003 2003-11-13 2003-11-13 IN2003CH00929A (zh)

Priority Applications (5)

Application Number Priority Date Filing Date Title
IN929CH2003 IN2003CH00929A (zh) 2003-11-13 2003-11-13
PCT/IB2004/052294 WO2005047457A2 (en) 2003-11-13 2004-11-04 Polyisoprenyl benzophenones as inhibitors of histone acetyl transferases and uses thereof
US10/579,219 US7402706B2 (en) 2003-11-13 2004-11-04 Polyisoprenylated benzophenones and their isomers as inhibitors of histone acetyltransferases and uses thereof
AT04799059T ATE549309T1 (de) 2003-11-13 2004-11-04 Polyisoprevonl benzophenone als inhibitoren von histonacetyltransdferasen und anwendungen dafür
EP04799059A EP1694622B1 (en) 2003-11-13 2004-11-04 Polyisoprenyl benzophenones as inhibitors of histone acetyl transferases and uses thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN929CH2003 IN2003CH00929A (zh) 2003-11-13 2003-11-13

Publications (1)

Publication Number Publication Date
IN2003CH00929A true IN2003CH00929A (zh) 2008-10-06

Family

ID=34586954

Family Applications (1)

Application Number Title Priority Date Filing Date
IN929CH2003 IN2003CH00929A (zh) 2003-11-13 2003-11-13

Country Status (5)

Country Link
US (1) US7402706B2 (zh)
EP (1) EP1694622B1 (zh)
AT (1) ATE549309T1 (zh)
IN (1) IN2003CH00929A (zh)
WO (1) WO2005047457A2 (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022254465A1 (en) * 2021-06-02 2022-12-08 Council Of Scientific And Industrial Research An Indian Registered Body Incorporated Under The Regn. Of Soc. Act (Act Xxi Of 1860) Small molecule modulator targeting a rare histone modification regulating adipogenesis and pharmaceutical formulation thereof

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA200800321A1 (ru) 2005-07-14 2008-06-30 Такеда Сан Диего, Инк. Ингибиторы гистондеацетилазы
AR057579A1 (es) * 2005-11-23 2007-12-05 Merck & Co Inc Compuestos espirociclicos como inhibidores de histona de acetilasa (hdac)
KR101005173B1 (ko) * 2008-02-18 2011-01-04 인제대학교 산학협력단 항산화 및 세포독성 활성을 나타내는 물레나물과의가르시니아 오블롱기폴리아로부터 추출된 분획물 및그로부터 분리된 화합물
US20120165384A1 (en) * 2009-09-07 2012-06-28 Jawaharlal Nehru Centre For Advanced Scientific Research Inhibition of histone acetyltransferases by ctk7a and methods thereof
CA2820984C (en) * 2010-12-09 2016-10-11 Indus Biotech Private Limited A complex of garcinol, cyclodextrin and method thereof
WO2013148114A1 (en) * 2012-03-30 2013-10-03 University Of Florida Research Foundation, Inc. P300/cbp inhibitors and methods of use
GB201215942D0 (en) * 2012-09-06 2012-10-24 Glaxo Group Ltd Method of treatent
EP3614846A4 (en) * 2017-06-22 2021-01-13 Sami Labs Limited GARCINOL COMPOSITIONS FOR THE THERAPEUTIC MANAGEMENT OF STRESS IN THE ENDOPLASMATIC RETICULUM
EP3681885B1 (en) 2017-09-15 2024-02-28 Forma Therapeutics, Inc. Tetrahydro-imidazo quinoline compositions as cbp/p300 inhibitors
MX2023013508A (es) 2018-06-29 2023-12-13 Forma Therapeutics Inc Inhibicion de la proteina de union a creb (cbp).
US11795168B2 (en) 2020-09-23 2023-10-24 Forma Therapeutics, Inc. Inhibiting cyclic amp-responsive element-binding protein (CREB) binding protein (CBP)
US11801243B2 (en) 2020-09-23 2023-10-31 Forma Therapeutics, Inc. Bromodomain inhibitors for androgen receptor-driven cancers

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08259493A (ja) * 1995-03-20 1996-10-08 Sugimoto Masami 抗ｍｒｓａ活性物質

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022254465A1 (en) * 2021-06-02 2022-12-08 Council Of Scientific And Industrial Research An Indian Registered Body Incorporated Under The Regn. Of Soc. Act (Act Xxi Of 1860) Small molecule modulator targeting a rare histone modification regulating adipogenesis and pharmaceutical formulation thereof

Also Published As

Publication number Publication date
WO2005047457B1 (en) 2005-12-01
US7402706B2 (en) 2008-07-22
US20070254961A1 (en) 2007-11-01
EP1694622A2 (en) 2006-08-30
WO2005047457A2 (en) 2005-05-26
ATE549309T1 (de) 2012-03-15
EP1694622B1 (en) 2012-03-14
WO2005047457A3 (en) 2005-08-04

Similar Documents

Publication Publication Date Title
IN2003CH00929A (zh)
DE60137329D1 (de) Zusammensetzungen zur behandlung von diabetes die einen dp iv-inhibitoren und einen andere antidiabetikum enthalten
NO20055741L (no) Nye kjemiske forbindelser
NO20050570L (no) Nye forbindelser, preparater og fremgangsmater for behandling av inflammasjonssykdommer og -tilstander
DK1490077T3 (da) Lysbeskyttende oralt administrerbar sammensætning til hud
CY2014028I1 (el) Ενωσεις, φαρμακοτεχνικες μορφες και μεθοδοι θεραπειας ή αποτροπhς ροδοχρωμης ακμης
ATE428698T1 (de) Die aktivität von gamma-secretase blockierende malonamidderivate
AR091405A2 (es) Omega-carboxiaril difenil urea sustituida con fluoro y composiciones farmaceuticas que las contienen
DE602004021685D1 (de) Markierungsfreier nachweis biologischer und chemischer stoffe mittels evaneszenzfeld
ATE386028T1 (de) Zyklohexylsulfone als gamma-sekretase-inhibitoren
ATE347451T1 (de) Abgabevorrichtung
NO20050738L (no) Ny fremgangsmate for syntesen av (7-metoksy-3,4-dihydro-1-naftalanyl)acetonitril og dens anvendelse i syntesen av agomelatin
ATE542804T1 (de) 5-phenyl-pentansäurederivate als matrixmetalloproteinase-inhibitoren zur behandlung von asthma und anderen erkrankungen
ATE424823T1 (de) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin- derivate als arzneimittel zur behandlung von unfruchtbarkeit
ATE497500T1 (de) Kristalline base von escitalopram und orodispergierbare tabletten, die escitaloprambase enthalten
ATE422201T1 (de) 4-(heterocyclyl)-benzenesulfoximin verbindungen zur behandlung entzündlicher erkrankungenen
SE0302304D0 (sv) Novel compounds
ITRN20030024A1 (it) Dispositivo per il prelievo di campioni biologici e/o chimici.
ITSV20030016A1 (it) Sostanze contenenti tannini o miscele di tannini.
ATE460425T1 (de) Histondeacetylaseinhibitor und verfahren zu dessen herstellung
ATE295724T1 (de) Der duale inhibitor der cholesterylester und wachsester synthese avasimibe zur behandlung von erkrankungen des talgdrüse
DE602004026067D1 (de) Gerät zur Behandlung von Füßen
FR2861630B1 (fr) Appareil pour le tranchage de materiau en plaques et dispositif de collecte associe
DE60316050D1 (de) Vorrichtung zur anpassung der sensitivität eines implantierbaren medizinprodukts
DE602004031313D1 (de) Vorrichtung zur Aktivierung eines ionisierbaren Produkts